In 2016, a randomized trial from NYU found that a single dose of psilocybin delivered rapid improvements in anxiety and depression in cancer patients when combined with psychotherapy. A follow-up study found that 71–100% of participants reported that the improvement in depression and anxiety had lasted five years—with participants “rating it among the most personally meaningful experiences of their lives.”
Interesting study and promising.
I hope it will work exactly as described. Just how long the development phase will be, I guess, is unknown.